Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Tag: Roche

Clinical Catch-Up: January 10-14

Roche Presents Positive Clinical Data for Neurology Programs at EAN Annual Meeting

via: Roche presented results from several Phase II and III trials at the 7th Congress of the European Academy of Neurology (EAN) Annual Meeting held virtually June 19-22. Some of the results specifically underscored the efficacy and safety of EVRYSDI™ (risdiplam) for motor neuron disease, Enspryng® (satralizumab)

Read More »
Roche Drug for Spinal Muscular Atrophy

Roche Drug for Spinal Muscular Atrophy Hits Target in Late-Stage Trial

VIA: ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug risdiplam improved motor function in a key study. Roche, which plans to seek approval for

Read More »